2026年

1. Sasagawa H, Endo M, Iwasaki Y, Usui Y, Koyanagi YN, Innella G, Hadler J, Parsons MT, Numakura K, Kamatani Y, Murakami Y, Matsuo K, Matsuda K, Spurdle AB, Habuchi T, *Momozawa Y. BRCA1 and BRCA2 pathogenic variants increase the risk of four less common cancer types. ESMO Open. 2026

2025年

1. #Takehara Y, #Usui Y, Stolařová L, Kleiblova P, Iwasaki Y, Johnson TA, Hirata M, Kamatani Y, Murakami Y, Endo M, Shiraishi K, Kohno T, Sugano K, Matsuda K, Yoshida T, Spurdle AB, Nakagawa H, Macurek L, Kleibl Z, *Momozawa Y. Case-Control Study for 23 Cancer Types With Functional Analysis of CHEK2: Risk Estimation and Clinical Recommendation in East Asia. JCO Precis Oncol. 2025;9:e2400945.
2. Mizukami K, Usui Y, Iwasaki Y, Shiraishi K, Hirata M, Kamatani Y, Endo M, Takahashi S, Mochizuki Y, Yamaguchi M, Kohno T, Matsuda K, Sugano K, Yoshida T, Nakagawa H, Terao C, Koyanagi YN, Matsuo K, Murakami Y, Spurdle AB, *Momozawa Y. Pan-cancer prevalence, risk, and clinical and demographic characteristics of Lynch Syndrome-associated variants in BioBank Japan. Commun Med. 2025;5(1):522.
3. *Usui Y, Endo M, Iwasaki Y, Iijima H, Nakagawa H, Matsuda K, *Momozawa Y. Clinical Significance of TP53-Mutant Clonal Hematopoiesis Across Diseases. Blood Cancer Discov. 2025;6(4):298–306.
4. *Shimomura Y, Komukai S, Kitamura T, Yoshimura K, Inamoto Y, Akahoshi Y, Kuwatsuka Y, Usui Y, Uchida N, Tanaka M, Onizuka M, Sakata-Yanagimoto M, Doki N, Hasegawa Y, Ishiwata K, Nakamae H, Sawa M, Katayama Y, Kawakita T, Yoshimitsu M, Fukuda T, Kanda Y, Ohbiki M, Nakasone H, Kanda J. A win ratio approach for comparing graft-versus-host disease-free, relapse-free survival among alternative donors. Br J Haematol. 2025;207(3):946–55.
5. Kanazashi Y, Usui Y, Iwasaki Y, Sasagawa S, Endo M, Yamaguchi M, Johnson TA, Maejima K, Shiraishi K, Kohno T, Yoshida T, Sugano K, Murakami Y, Kamatani Y, Matsumoto N, Matsuda K, *Momozawa Y, *Nakagawa H. Cancer and disease profiles for PTEN pathogenic variants in Japanese population. J Hum Genet. 2025;70(3):135–40.

2024年

1. Okada Y, Usui Y, Hayashi H, Nishikubo M, Toubai T, Uchida N, Tanaka M, Onizuka M, Takahashi S, Doki N, Uehara Y, Maruyama Y, Ishiwata K, Kawakita T, Sawa M, Eto T, Ishimaru F, Kato K, Fukuda T, Atsuta Y, Kanda J, Yakushijin K, *Nakasone H. Development of an umbilical cord blood transplantation-specific nonrelapse mortality risk assessment score. Blood Adv. 2024;8(6):1359–68.
2. Glennon KI, Endo M, Usui Y, Iwasaki Y, Breau RH, Kapoor A, Lathrop M, *Tanguay S, *Momozawa Y, *Riazalhosseini Y. Germline Susceptibility to Renal Cell Carcinoma and Implications for Genetic Screening. JCO Precis Oncol. 2024;8:e2400094.

2023年

1. Usui Y, *Ito H, Katanoda K, Matsuda T, Maeda Y, Matsuo K. Trends in non-Hodgkin lymphoma mortality rate in Japan and the United States: A population-based study. Cancer Sci. 2023;114(10):4073–80.
2. Usui Y, *Momozawa Y. Personalized medicine with germline pathogenic variants: Importance of population- and region-wide evidence. Cancer Sci. 2023;114(10):3816–24.
3. Usui Y, Matsuo K, *Momozawa Y. Helicobacter pylori, Homologous-Recombination Genes, and Gastric Cancer. Reply. N Engl J Med. 2023;389(4):379–81.
4. Usui Y, Taniyama Y, Endo M, Koyanagi YN, Kasugai Y, Oze I, Ito H, Imoto I, Tanaka T, Tajika M, Niwa Y, Iwasaki Y, Aoi T, Hakozaki N, Takata S, Suzuki K, Terao C, Hatakeyama M, Hirata M, Sugano K, Yoshida T, Kamatani Y, Nakagawa H, Matsuda K, Murakami Y, Spurdle AB, *Matsuo K, *Momozawa Y. Helicobacter pylori, Homologous-Recombination Genes, and Gastric Cancer. N Engl J Med. 2023;388(13):1181–90.
5. *Kamijo K, Shimomura Y, Shinohara A, Mizuno S, Kanaya M, Usui Y, Kim SW, Ara T, Mizuno I, Kuriyama T, Nakazawa H, Matsuoka KI, Kusumoto S, Maseki N, Yamaguchi M, Ashida T, Onizuka M, Fukuda T, Atsuta Y, Kondo E. Fludarabine plus reduced-intensity busulfan versus fludarabine plus myeloablative busulfan in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic cell transplantation. Ann Hematol. 2023;102(3):651–61.
6. Kambara Y, *Fujii N, Usui Y, Yamamoto A, Higo H, Fujiwara H, Asada N, Ennishi D, Nishimori H, Fujii K, Matsuoka KI, Maeda Y. Association between early corticosteroid administration and long-term survival in non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation. Int J Hematol. 2023;117(4):578–89.

2022年

1. Usui Y, Iwasaki Y, Matsuo K, Endo M, Kamatani Y, Hirata M, Sugano K, Yoshida T, Matsuda K, Murakami Y, Maeda Y, Nakagawa H, *Momozawa Y. Association between germline pathogenic variants in cancer-predisposing genes and lymphoma risk. Cancer Sci. 2022;113(11):3972–9.
2. *Momozawa Y, Sasai R, Usui Y, Shiraishi K, Iwasaki Y, Taniyama Y, Parsons MT, Mizukami K, Sekine Y, Hirata M, Kamatani Y, Endo M, Inai C, Takata S, Ito H, Kohno T, Matsuda K, Nakamura S, Sugano K, Yoshida T, Nakagawa H, Matsuo K, Murakami Y, Spurdle AB, Kubo M. Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants. JAMA Oncol. 2022;8(6):871–8.
3. Kitamura W, *Fujii N, Nawa Y, Fujishita K, Sugiura H, Yoshioka T, Fujiwara Y, Usui Y, Fujii K, Fujiwara H, Asada N, Nishimori H, Matsuoka KI, Maeda Y. Possible prognostic impact of WT1 mRNA expression at day + 30 after haploidentical peripheral blood stem cell transplantation with posttransplant cyclophosphamide for patients with myeloid neoplasm: a multicenter study from the Okayama Hematological Study Group. Int J Hematol. 2022;115(4):515–
4. Kasugai Y, Kohmoto T, Taniyama Y, Koyanagi YN, Usui Y, Iwase M, Oze I, Yamaguchi R, Ito H, Imoto I, *Matsuo K. Association between germline pathogenic variants and breast cancer risk in Japanese women: The HERPACC study. Cancer Sci. 2022;113(4):1451–62.
5. *Kameda K, Kako S, Kim SW, Usui Y, Kato K, Fukuda T, Uchida N, Kobayashi H, Wakayama T, Sakaida E, Yano S, Imada K, Nara M, Ikeda T, Fuchida SI, Ishikawa J, Sugahara H, Kanda J, Kimura T, Ichinohe T, Atsuta Y, Kondo E. Autologous or allogeneic hematopoietic cell transplantation for relapsed or refractory PTCL-NOS or AITL. Leukemia. 2022;36(5):1361–70.
6. *Inoue-Choi M, Freedman ND, Saito E, Tanaka S, Hirabayashi M, Sawada N, Tsugane S, Usui Y, Ito H, Wang C, Tamakoshi A, Takeuchi T, Kitamura Y, Utada M, Ozasa K, Sugawara Y, Tsuji I, Wada K, Nagata C, Shimazu T, Mizoue T, Matsuo K, Naito M, Tanaka K, Katanoda K, Inoue M. Low-intensity cigarette smoking and mortality risks: a pooled analysis of prospective cohort studies in Japan. Int J Epidemiol. 2022;51(4):1276–90.

2021年以前（一部抜粋）

1. Usui Y, *Matsuo K, Oze I, Ugai T, Koyanagi Y, Maeda Y, Ito H, Hishida A, Takeuchi K, Tamura T, Tsukamoto M, Kadomatsu Y, Hara M, Nishida Y, Shimoshikiryo I, Takezaki T, Ozaki E, Matsui D, Watanabe I, Suzuki S, Watanabe M, Nakagawa-Senda H, Mikami H, Nakamura Y, Arisawa K, Uemura H, Kuriki K, Takashima N, Kadota A, Ikezaki H, Murata M, Nakatochi M, Momozawa Y, Kubo M, Wakai K. Impact of PSCA Polymorphisms on the Risk of Duodenal Ulcer. J Epidemiol. 2021;31(1):12–20.
2. #*Seo S, #Usui Y, Matsuo K, Atsuta Y, Igarashi A, Fukuda T, Ozawa Y, Katayama Y, Yoshida S, Uchida N, Kondo T, Kako S, Tsukada N, Kato S, Onizuka M, Ichinohe T, Kimura F, Kanda Y, Miyamura K, Kanda J. Impact of the combination of donor age and HLA disparity on the outcomes of unrelated bone marrow transplantation. Bone Marrow Transplant. 2021;56(10):2410–22.
3. Usui Y, *Ito H, Koyanagi Y, Shibata A, Matsuda T, Katanoda K, Maeda Y, Matsuo K. Changing trend in mortality rate of multiple myeloma after introduction of novel agents: A population-based study. Int J Cancer. 2020;147(11):3102–9.